Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8351 to 8400 of 8904 results

  1. Gantenerumab for treating early Alzheimer's disease [ID6142]

    In development Reference number: GID-TA11269 Expected publication date: TBC

    Technology appraisal guidance
    In development

  2. Alpelisib with olaparib for treating BRCA wild-type platinum-refractory or -resistant ovarian, fallopian tube or primary peritoneal cancer after 1 to 3 previous treatments [ID6247]

    In development Reference number: GID-TA11251 Expected publication date: TBC

    Technology appraisal guidance
    In development

  3. Giroctocogene fitelparvovec for treating moderately severe to severe haemophilia A [ID6312]

    In development Reference number: GID-TA11329 Expected publication date: TBC

    Technology appraisal guidance
    In development

  4. Fidrisertib for reducing heterotopic ossification caused by fibrodysplasia ossificans progressiva in people 5 years and over [ID6678]

    In development Reference number: GID-TA11805 Expected publication date: TBC

    Technology appraisal guidance
    In development

  5. Eteplirsen for treating Duchenne muscular dystrophy [ID1003]

    Discontinued Reference number: GID-HST10007

    Highly specialised technologies guidance
    Discontinued

  6. Diabetic foot ulcers - new treatments [ID381]

    Discontinued Reference number: GID-TAG371

    Technology appraisal guidance
    Discontinued

  7. Laparoscopic radical hysterectomy for early stage cervical cancer (IPG338)

    This guidance has been updated and replaced by NICE HealthTech guidance 565.

    Withdrawn guidance

  8. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (CG144)

    This guidance has been updated and replaced by NICE guideline NG158.

    Withdrawn guideline

  9. Motor neurone disease: non-invasive ventilation (CG105)

    This guideline has been updated and replaced by NICE guideline 42. 

    Withdrawn guideline

  10. Barrett's oesophagus: ablative therapy (CG106)

    This guidance has been updated and replaced by NICE guideline NG231.

    Withdrawn guideline

  11. Hypertension in pregnancy: diagnosis and management (CG107)

    This guidance has been updated and replaced by NICE guideline NG133

    Withdrawn guideline

  12. Chronic heart failure in adults: management (CG108)

    This guideline has been updated and replaced by NICE guideline NG106.

    Withdrawn guideline

  13. Fertility: assessment and treatment for people with fertility problems (CG11)

    This guideline has been updated and replaced by NICE guideline CG156.

    Withdrawn guideline

  14. Neonatal infection (early onset): antibiotics for prevention and treatment (CG149)

    This guidance has been updated and replaced by NICE guideline NG195.

    Withdrawn guideline

  15. Diagnosis and management of type 1 diabetes in children, young people and adults (CG15)

    This guidance has been updated and replaced by NICE guidelines NG17, NG18 and NG19.

    Withdrawn guideline

  16. Crohn's disease: management (CG152)

    This guidance has been updated and replaced by NICE guideline NG129.

    Withdrawn guideline

  17. Ectopic pregnancy and miscarriage: diagnosis and initial management (CG154)

    This guidance has been updated and replaced by NICE guideline NG126

    Withdrawn guideline

  18. Epilepsies: diagnosis and management (CG137)

    This guidance has been updated and replaced by NICE guideline NG217.

    Withdrawn guideline

  19. Familial breast cancer (CG14)

    This guidance has been updated and replaced by NICE guideline CG41.

    Withdrawn guideline

  20. Anaemia management in people with chronic kidney disease (CG114)

    This guideline has been updated and replaced by NICE guideline NG8.

    Withdrawn guideline

  21. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control (CG117)

    This guidance has been updated and replaced by NICE guideline NG33.

    Withdrawn guideline

  22. Diabetic foot problems: Inpatient management of diabetic foot problems (CG119)

    This guidance has been updated and replaced by NICE guideline NG19.

    Withdrawn guideline

  23. Chronic obstructive pulmonary disease: Management of chronic obstructive pulmonary disease in adults in primary and secondary care (CG12)

    This guideline has been updated and replaced by NICE guideline CG101.

    Withdrawn guideline

  24. Lung cancer: diagnosis and management (CG121)

    This guidance has been updated and replaced by NICE guideline NG122.

    Withdrawn guideline

  25. Common mental health problems: identification and pathways to care (CG123)

    We withdrew this guideline in May 2024, because all of the recommendations are now covered in other NICE guidelines, or are out of date and no longer relevant to clinical practice. For guidance on common mental health problems, see our guidelines on: Depression in adults Depression in adults with a chronic physical health problem Depression in children and young people Generalised anxiety disorder and panic disorder in adults Obsessive-compulsive disorder and body dysmorphic disorder Social anxiety disorder

    Withdrawn guideline

  26. Chronic kidney disease (stage 5): peritoneal dialysis (CG125)

    This guidance has been updated and replaced by NICE guideline NG107.

    Withdrawn guideline

  27. Hypertension in adults: diagnosis and management (CG127)

    This guidance has been updated and replaced by NICE guideline NG136.

    Withdrawn guideline

  28. Multiple pregnancy: antenatal care for twin and triplet pregnancies (CG129)

    This guideline has been updated and replaced by NICE guideline NG137

    Withdrawn guideline

  29. Caesarean section (CG13)

    This guideline has been updated and replaced by NICE guideline CG132.

    Withdrawn guideline

  30. Hyperglycaemia in acute coronary syndromes: management (CG130)

    This guideline has been replaced by NICE guideline NG185.

    Withdrawn guideline

  31. Colorectal cancer: diagnosis and management (CG131)

    This guidance has been updated and replaced by NICE guideline NG151.

    Withdrawn guideline

  32. Caesarean section (CG132)

    This guidance has been updated and replaced by NICE guideline NG192 and the recommendations on multiple pregnancy have been updated and replaced by NICE guideline NG137. 

    Withdrawn guideline

  33. Self-harm in over 8s: long-term management (CG133)

    This guidance has been updated and replaced by NICE guideline NG225.

    Withdrawn guideline

  34. Type 2 diabetes foot problems: Prevention and management of foot problems (CG10)

    This guidance has been updated and replaced by NICE guideline NG19.

    Withdrawn guideline

  35. Schizophrenia (CG1)

    This guidance has been updated and replaced by NICE guideline CG82.

    Withdrawn guideline

  36. Chronic obstructive pulmonary disease in over 16s: diagnosis and management (CG101)

    This guideline has been updated and replaced by NICE guideline NG115.

    Withdrawn guideline

  37. Meningitis (bacterial) and meningococcal septicaemia in under 16s: recognition, diagnosis and management (CG102)

    This guideline has been updated and replaced by NICE guideline NG240.

    Withdrawn guideline

  38. Chronic kidney disease (stage 4 or 5): management of hyperphosphataemia (CG157)

    This guidance has been updated and replaced by NICE guideline NG203.

    Withdrawn guideline

  39. Self-harm in over 8s: short-term management and prevention of recurrence (CG16)

    This guidance has been updated and replaced by NICE guideline NG225.

    Withdrawn guideline

  40. Fever in under 5s: assessment and initial management (CG160)

    This guidance has been updated and replaced by NICE guideline NG143.

    Withdrawn guideline

  41. Falls in older people: assessing risk and prevention (CG161)

    This guideline has been updated and replaced by NICE guideline NG249.

    Withdrawn guideline

  42. Hypertension (CG18)

    This guidance has been updated and replaced by NICE guideline CG34.

    Withdrawn guideline

  43. Atrial fibrillation: management (CG180)

    This guidance has been updated and replaced by NICE guideline NG196.

    Withdrawn guideline

  44. Cardiovascular disease: risk assessment and reduction, including lipid modification (CG181)

    This guideline has been updated and replaced by NICE guideline NG238.

    Withdrawn guideline

  45. Chronic kidney disease in adults: assessment and management (CG182)

    This guidance has been updated and replaced by NICE guideline NG203.

    Withdrawn guideline

  46. Dyspepsia: Management of dyspepsia in adults in primary care (CG17)

    This guidance has been updated and replaced by NICE guideline CG184.

    Withdrawn guideline

  47. Urinary incontinence in women: management (CG171)

    This guideline has been updated and replaced by NICE guideline NG123.

    Withdrawn guideline

  48. Myocardial infarction: cardiac rehabilitation and prevention of further cardiovascular disease (CG172)

    This guideline has been updated and replaced by NICE guideline NG185.

    Withdrawn guideline

  49. Prostate cancer: diagnosis and management (CG175)

    This guideline has been updated and replaced by NICE guideline NG131.

    Withdrawn guideline

  50. Head injury: assessment and early management (CG176)

    This guideline has been updated and replaced by the NICE guideline on head injury: assessment and management (NG232).

    Withdrawn guideline